Researchers find higher risks of adverse events, underutilized options for mitigation.
New evidence reveals a critical regulatory role for non-coding RNAs in inflammatory diseases, including rheumatoid arthritis.
New studies explore advances in standard and immunosuppressive therapies.
Acting as biomarkers, microbial sRNAs indicate disease severity and drug responses.
Join our rheumatology experts as they present their latest research and innovations in clinical care.
Handheld device provides an objective approach to measuring sclerosis.
Drug response variability showcases opportunities for precision medicine.
1 / 5
A specialist on CTD-ILD says misdiagnosis and delayed treatment remain common.
Despite guidelines, hydroxychloroquine prescriptions are lagging.
Research identifies transcription factor involved in triggering or tampering defense.